LFVN Lifevantage

LifeVantage To Open Iceland Market

LifeVantage To Open Iceland Market

Launch delivers innovative business opportunity and top wellness products to Iceland, marking a bold step in European expansion

SALT LAKE CITY, July 24, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced its upcoming launch into Iceland expected in September. This marks the company’s continued partnership with its field leadership on international expansion and reinforces its commitment to delivering science-backed wellness solutions to consumers around the world.

The Iceland launch will begin with a carefully selected lineup of LifeVantage’s top-performing products:

  • ®: a flagship product known for its cellular defense and antioxidant-support properties.
  • : a cutting-edge system supporting metabolic wellness and healthy weight management.
  • : a customer favorite designed to support skin elasticity and hydration.
  • : a targeted probiotic formula aligning with Iceland’s strong gut health culture.

In addition, customers in Iceland will have access to three curated wellness stacks designed to support different health goals:



The company plans to introduce additional products into the Icelandic market over time.

Along with the introduction of its activation products comes the launch of the LifeVantage business opportunity, powered by the industry-leading Evolve Compensation Plan. Consultants can prepare to enroll for the launch into Iceland by sending an inquiry to .

“We’re incredibly excited to launch in Iceland and welcome a new community of passionate entrepreneurs to Activation Nation,” said Steve Fife, President and CEO of LifeVantage. “This expansion represents more than just business growth—it’s a meaningful step in our mission to empower individuals with the tools, support, and science-backed products they need to take control of their health and build their own success stories. We look forward to the positive impact our launch will have in this vibrant new market and the success Consultants will have here.”

This announcement underscores LifeVantage’s broader strategy to grow its international footprint and deliver high-impact wellness solutions to an expanding global customer base.

For more information on LifeVantage, the Evolve Compensation Plan, and its activating products, visit .

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit *

Public Relations Contact:

CerconeBrownCompany

Investor Relations Contact:

Reed Anderson, ICR

(646) 277-1260



EN
24/07/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter ...

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2025 SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2025. Fourth Quarter Fiscal 2025 Summary*: Revenue of $55.1 million, an increase of 12.6% from the prior year period. Excluding the impact of foreign currency fluctuations, fourth quarter r...

 PRESS RELEASE

LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership i...

LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership in Direct Sales, Microbiome Health and Wellness Strategic acquisition expands network of Consultants, and strengthens LifeVantage's Activation differentiation in the rapidly growing gut health market SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced it has entered into a definitive agreement to acquire LoveBiome, a pioneering direct sales company...

 PRESS RELEASE

LifeVantage to Participate in the H.C. Wainwright 27th Annual Global I...

LifeVantage to Participate in the H.C. Wainwright 27th Annual Global Investment Conference SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the H.C. Wainwright 27th Annual Global Investment Conference, to be held September 8-10, 2025 in New York, NY. Mr. Fife and Mr. Aure will meet with investors and...

 PRESS RELEASE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Aug. 28, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid September 16, 2025 to all stockholders of record at the close of business on September 8, 2025. About LifeVantage Corporation LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a...

 PRESS RELEASE

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2025 Resul...

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2025 Results on September 4, 2025 SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2025, after the stock market closes on Thursday, September 4, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) tha...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch